Bu çeviri hazırlanıyor. Bu süre içinde İngilizce orijinal sürümü gösteriyoruz.
İş dünyası · 14.10.19941 dk okuma
National Cancer Institute; Opportunity for a Cooperative Research Agreement (CRADA) for the Clinical Evaluation of Magnetic Resonance Imaging in Breast Cancer
Yerel otomatik çeviri · Kaynağın orijinal dili
Özet
The National Cancer Institute (NCI) seeks major pharmaceutical companies that can effectively pursue the joint research, development, evaluation and commercialization of imaging drugs to be used for magnetic resonance imaging (MRI) in breast cancer. NCI will enter into CRADA negotiations with the sponsor(s) of the selected proposal(s).
Kaynağın orijinal dili: Federal Register — Health and Human ServicesOrijinal duyuruyu açın →